Cassidy Targets March-In Rights Again After Supreme Court's Ruling On Chevron Deference

By Jalen Brown, Gabrielle Wanneh / July 1, 2024 at 7:00 PM
Sen. Bill Cassidy (R-LA) is putting march-in authority back in his crosshairs in the wake of the Supreme Court's decision to overturn the Chevron deference, which required courts to defer to agency interpretations of ambiguous statutory provisions. In a letter sent to HHS Secretary Xavier Becerra on Sunday (June 30), the ranking Republican on the Senate health committee requested the secretary clarify the legal basis for the National Institutes of Health’s (NIH) proposed framework to use drug pricing as...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.